UPDATE: Morgan Stanley Reduces PT to $8.60 on Fibria Celulose; Q1 Miss, Balance Sheet
Morgan Stanley reduces its price target from $9.10 to $8.60 on Equal-weight-rated Fibria Celulose (NYSE: FBR) on Q1 miss and balance sheet concerns.
Morgan Stanley comments, "1Q12 EBITDA came below our estimate on the back of higher-than-expected cash costs. Management is working diligently to improve FBR's balance sheet, but ND/EBITDA remains elevated and it still poses a risk in the event that China's pulp imports slow down and, consequently, pulp prices decline."
FBR closed at $7.10 on Monday.
Latest Ratings for FBR
|Sep 2014||Morgan Stanley||Downgrades||Overweight||Equalweight|
|Jul 2014||Bank of America||Downgrades||Buy||Neutral|
|May 2014||JP Morgan||Maintains||Overweight|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.